Abbonarsi

Long-term outcome of patients with vasovagal syncope - 26/08/11

Doi : 10.1016/j.ahj.2003.11.022 
Gonzalo Barón-Esquivias, MD, PhD, FESC a, , Francisco Errázquin, MD, PhD a, Alonso Pedrote, MD, PhD a, Aurelio Cayuela, MD, MPH b, Silvia Gómez, MD a, Almudena Aguilera, MD a, Ana Campos, MD a, Mónica Fernández, MD a, Juan I Valle, RN a, Mercedes Redondo, RN a, José M Fernández, RN a, Ángel Martínez, MD, PhD a, José Burgos, MD, PhD a, Antoni Martínez-Rubio, MD, PhD, FESC, FACC c
a Cardiology Department, Virgen del Rocío University Hospitals, Seville, Spain 
b Supportive Unit for Research, Virgen del Rocío University Hospitals, Seville, Spain 
c Cardiology Department, Hospital Parc Taulí, Sabadell, Spain 

*Reprint requests: Gonzalo Barón-Esquivias, MD, Avenida de Portugal, 19, 41004-Sevilla, Spain.

Abstract

Background

After abnormal head-up tilt test (HUT), several trials have evaluated treatment strategies for vasovagal syncope (VVS). However, few unequivocal results have been obtained. The aim of the study was to prospectively analyze the natural history of patients with VVS who did not undergo specific treatment but received education for avoiding syncope after an abnormal HUT.

Methods

From 1996, 334 consecutive patients with VVS and an abnormal HUT result were followed. All of them received education for avoiding syncope as first-line therapy.

Results

During 30.4 ± 21 months, there were no cardiac deaths. However, 101 patients (30.2%) had recurrences (1 recurrence, n = 64; ≥2, n = 37), which were not influenced by the type of response during HUT or by age. Time to first recurrence was correlated with the number of recurrences (r: −0.34, P = .0001). Mean recurrence-free time was 50.1 months (95% CI 46–54) and the cumulative probability of no recurrence was 69.8%. Receiver operator character curve analysis, demonstrated significant differences in the recurrence rate between patients with <5 or ≥5 previous episodes of syncope (25.1% vs 44%; P = .001). In addition, the mean recurrence-free time of patients with <5 episodes was significantly longer (54.1 months) than in patients with ≥5 episodes (39.6 months; P = .0005). Multivariate logistic regression identified the previous number of episodes as an independent risk marker of recurrences (odds ratio 2.34, 95% CI 1.4–3.8, P = .001). Age (at HUT performance) as a continuous variable was not a predictor of outcome.

Conclusions

Survival of patients with VVS presenting after an abnormal HUT is excellent. Although the broad majority of those patients do not suffer recurrences after education, the number of previous syncopal episodes critically influences the recurrence rate.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


© 2004  Elsevier Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 147 - N° 5

P. 883-889 - Maggio 2004 Ritorno al numero
Articolo precedente Articolo precedente
  • Vascular basis for the treatment of myocardial ischemia study: Trial design and baseline characteristics
  • Peter H Stone, Donald M Lloyd-Jones, Michael Johnstone, William Carlson, Joel Rubenstein, Mark Creager, Balz Frei, George Sopko, Maureen E Clark, Gail MacCallum, Scott Kinlay, John Orav, Andrew P Selwyn
| Articolo seguente Articolo seguente
  • Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes
  • Todd D Miller, Navin Rajagopalan, David O Hodge, Robert L Frye, Raymond J Gibbons

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2024 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.